Thomas A. West - 31 Dec 2022 Form 5 Insider Report for Orthofix Medical Inc. (OFIX)

Role: Director
Signature: /s/ Kimberley Elting, President, Global Orthopedics, by power of attorney
Issuer symbol: OFIX
Transactions as of: 31 Dec 2022
Net transactions value: +$6,989
Form type: 5
Filing time: 11 Jan 2023, 15:54:38 UTC
Previous filing: 08 Jun 2022
Next filing: 04 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OFIX	Common Stock	Award	$6,989	+512	+7.8%	$13.65	7,055	31 Oct 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Thomas A. West is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Shares purchased pursuant to the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, as Amended (the "Stock Purchase Plan") for the plan period ended October 31, 2022.
F2	Pursuant to the terms of the Stock Purchase Plan, shares are purchased at 85% of the fair market value of the Orthofix stock on the first day of the plan period or, if lower, on the last day of the plan period. Accordingly, shares were purchased at $13.65 per share, or at 85% of the quoted market price of $16.06 on October 31, 2022.